Early research (Phase 1)Study completedNCT07300202
What this trial is testing
CLINICAL RESEARCH PROTOCOL [A Phase I, Single-arm, Open-label, Dose-escalation Clinical Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers]
Who this might be right for
Evaluate the Safety Profile and Tolerability of Orialpha in Healthy Adult VolunteersBreast Cancer
Oriplantee Company Limited 15